ANTIBODY-DRUG CONJUGATE FORMED THROUGH TRANSGLUTAMINASE AND USE THEREOF

The present invention relates to a method of producing an antibody-medicine corporate body comprising a step of making mutated antibody including glutamine and medicine including free amine group react under the existence of transglutaminase, to an antibody-medicine corporate body produced thereby,...

Full description

Saved in:
Bibliographic Details
Main Authors MOON, KYUNG DUK, KO, MIN JI, PARK, SANG KYUNG, KIM, YOUNG MIN, SONG, DAE HAE
Format Patent
LanguageEnglish
Korean
Published 04.12.2013
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention relates to a method of producing an antibody-medicine corporate body comprising a step of making mutated antibody including glutamine and medicine including free amine group react under the existence of transglutaminase, to an antibody-medicine corporate body produced thereby, to an antibody-medicine corporate body in which medicine including mutated antibody and free amine group connected by isopeptide bond, to a composition for treating cancer including the antibody-medicine corporate body, to a method for treating cancer by using the antibody-medicine corporate body, and to a mutated body to which peptide including glutamine and antibody are connected.
AbstractList The present invention relates to a method of producing an antibody-medicine corporate body comprising a step of making mutated antibody including glutamine and medicine including free amine group react under the existence of transglutaminase, to an antibody-medicine corporate body produced thereby, to an antibody-medicine corporate body in which medicine including mutated antibody and free amine group connected by isopeptide bond, to a composition for treating cancer including the antibody-medicine corporate body, to a method for treating cancer by using the antibody-medicine corporate body, and to a mutated body to which peptide including glutamine and antibody are connected.
Author MOON, KYUNG DUK
PARK, SANG KYUNG
SONG, DAE HAE
KIM, YOUNG MIN
KO, MIN JI
Author_xml – fullname: MOON, KYUNG DUK
– fullname: KO, MIN JI
– fullname: PARK, SANG KYUNG
– fullname: KIM, YOUNG MIN
– fullname: SONG, DAE HAE
BookMark eNrjYmDJy89L5WRwd_QL8XTyd4nUdQkKdVdw9vfzCnV3DHFVcPMP8nV1UQjxCPIPdfdQCAly9At29wkNcfT19HMMdlVw9HNRCAXSIR6uQa7-bjwMrGmJOcWpvFCam0HZzTXE2UM3tSA_PrW4IDE5NS-1JN47yMjA0BiIjIyMzRyNiVMFANN5L1w
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID KR20130132236A
GroupedDBID EVB
ID FETCH-epo_espacenet_KR20130132236A3
IEDL.DBID EVB
IngestDate Fri Jul 19 11:30:19 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Korean
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_KR20130132236A3
Notes Application Number: KR20120154955
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20131204&DB=EPODOC&CC=KR&NR=20130132236A
ParticipantIDs epo_espacenet_KR20130132236A
PublicationCentury 2000
PublicationDate 20131204
PublicationDateYYYYMMDD 2013-12-04
PublicationDate_xml – month: 12
  year: 2013
  text: 20131204
  day: 04
PublicationDecade 2010
PublicationYear 2013
RelatedCompanies HANWHA CHEMICAL CORPORATION
RelatedCompanies_xml – name: HANWHA CHEMICAL CORPORATION
Score 2.8778362
Snippet The present invention relates to a method of producing an antibody-medicine corporate body comprising a step of making mutated antibody including glutamine and...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title ANTIBODY-DRUG CONJUGATE FORMED THROUGH TRANSGLUTAMINASE AND USE THEREOF
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20131204&DB=EPODOC&locale=&CC=KR&NR=20130132236A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dT8Iw8IJo1DdFjR9ommh4WxxuK_BAzFi7DXAdKZ3BJ7KOPRgNEJnx79s1oDzx1I9LLs0117vrfQE8ZC2JzbYsI2qaM8N2JDZSM28Z2Mw7VgenafpU5jtHDIeJPZg4kwp8bnJhdJ3QH10cUXFUpvi90O_18v8Ti-jYytWjfFdbi2dfdEljbR03reaTunTS69JRTGKv4XndIW8wrmHarWBhdw_2lSLdKvmBvvbKvJTltlDxT-BgpPDNi1OofCxqcORteq_V4DBau7zVdM19qzMIXCb6vZi8GYQnAfJiNkgCV1CkLLmIEiRCHidBiAR32Th4SYQb9Zk7pshlBCVqFCHlNPbP4d6nwgsNdaLpHwGmQ759fOsCqvPFPL8ElFq5bNuZUioyy3bSWVtibHakLNvvpqaTX0F9F6br3eAbOC6XOnjDrkO1-PrOb5UILuSdptwvHb2DCw
link.rule.ids 230,309,783,888,25576,76882
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dT8Iw8IJoxDdFjR-oSzS8LQ62lfFAzFi7jY91ZHQGn5Z17MFogMiMf9-uAeWJpza95HK55np3vS-Ap6zDkWbxMqOmNVcNkyM11fKOirS8q3dRmqbtst45oMiPjeHMnFXgc1sLI_uE_sjmiEKiMiHvhXyvV_-fWFjmVq6f-bs4Wr64rIebG--4pbfa4tJxv0cmIQ6dpuP0RlGTRhImwwo6sg_gUBjZVjnvgLz2y7qU1a5ScU_haCLwLYozqHws61BztrPX6nAcbELeYruRvvU5eDZlg36I31QcxZ7ihHQYezYjivDkAoIV5kdh7PkKi2w69cYxs4MBtadEsSlWYrEyn0QkdC_g0SXM8VVBUfLHgGQU7ZKvX0J1sVzkV6Ckes4tIxNGRaYbZjq3OEJal_Ny_G6qmfk1NPZhutkPfoCaz4JxMh7Q0S2clCCZyGE0oFp8fed3Qh0X_F5y8RdrcYX7
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=ANTIBODY-DRUG+CONJUGATE+FORMED+THROUGH+TRANSGLUTAMINASE+AND+USE+THEREOF&rft.inventor=MOON%2C+KYUNG+DUK&rft.inventor=KO%2C+MIN+JI&rft.inventor=PARK%2C+SANG+KYUNG&rft.inventor=KIM%2C+YOUNG+MIN&rft.inventor=SONG%2C+DAE+HAE&rft.date=2013-12-04&rft.externalDBID=A&rft.externalDocID=KR20130132236A